Despite many groups validated their instruments before use such as the EPIC-study (established in 1992-1994) and improved the dietary measurement by using a standardized 24-hour recall as calibration instrument, it is claimed that some of the recent conclusions from large-scale prospective cohort studies, for example that fruit and vegetable consumption is not related to risk of most cancer sites or that intake of saturated fat is not related to risk of breast cancer, could be due to the inability of the measurements to correctly rank participants by dietary intake level. Imprecision of the measurement instruments could also result in improper identification of vulnerable groups and inequality. Given that few large randomized clinical trials are available in the area of diet and risk of chronic diseases, particular cancer, the findings from large-scale prospective cohort studies provide the highest evidence for measures of public health policy at the Community and at the national level. Therefore, more advanced methods with higher discrimination power between individuals with different intake levels or levels of physical activity are urgently needed. The usage of more refined and quantitative methods to assess diet including alcohol use and of technical devices to measure physical activity could be considerably facilitated in terms of workload for the participants as well as for the researches if new information technologies such as web based tools or innovative communication facilities (e.g. photo cell phones) are applied in large-scale epidemiological studies.
New generation methods being applied in existing and upcoming large-scale epidemiological studies and other public health settings will generate the basis of knowledge on which the public health policy of the community can better rely on. From our point of view, it is a generic task of the public health program of the European community to establish the basis for efficient public health measures by financially supporting initiatives aiming at identification of best methods to be applicable in epidemiological and public health studies across and within various countries of Europe. The current proposal needs co-funding by the EU because it is far exceeding national perspectives and could not be done otherwise.